Xie et al. revealed that ERK phosphorylation was reduced in Ezrin-KD cells, and activation of the ERK/MAPK pathway might partially attenuate Ezrin-mediated suppression of cell invasiveness in esophageal squamous cell carcinoma [33]. The gene discussed is EZR; the disease is esophageal squamous cell carcinoma.